Antogen: SeedDevelops proteomics-based immune surveillance diagnostics and research tools for clinical and research marketsOct 4, 2026RoundOSAntogenCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeed · AIBiotechUnited StatesEnterprise softwareHealthtechNorth AmericaSeed